We have developed an experimental system to evaluate the effect of stress on small intestinal motility using a radionuclide 51 Cr 1, 2) and determined the inhibitory mechanism of small intestinal motility caused by the stress using the experimental system. [3] [4] [5] We reported that b 3 -adrenoceptors play an important role in the inhibition of small intestinal motility caused by restraint stress, while b 1 -, b 2 -, a 1 -, and a 2 -adrenoceptors did not 3) and that footshock stress canceled the inhibition by restraint stress via activation of m-opioid receptors.
Cr 1, 2) and determined the inhibitory mechanism of small intestinal motility caused by the stress using the experimental system. [3] [4] [5] We reported that b 3 -adrenoceptors play an important role in the inhibition of small intestinal motility caused by restraint stress, while b 1 -, b 2 -, a 1 -, and a 2 -adrenoceptors did not 3) and that footshock stress canceled the inhibition by restraint stress via activation of m-opioid receptors. 4 ) Moreover, we reported that the mechanism of the inhibition of small intestinal motility due to restraint stress and norepinephrine treatment were different since the norepinephrine-induced inhibition was recovered by the a 2 -adrenergic antagonist but was not by the b 3 -adrenergic antagonist. 5) It is well known that gastric emptying is also affected by various stresses. Many reports about various stresses affecting gastric emptying have been published, [6] [7] [8] [9] although its mechanism remained unclear.
In the present study, we attempted to ascertain the mechanism of the inhibition of gastric emptying by restraint and footshock stress and norepinephrine treatment.
MATERIALS AND METHODS

Animals
Male Wistar rats (6-weeks old, 150-200 g) purchased from the Japan Shizuoka Laboratory Animal Center (Hamamatsu, Japan), were used in all experiments. The animals were housed in a wire-mesh cage in a temperature (23Ϯ1°C)-and humidity (55Ϯ5%)-controlled room on a 12 h light-dark cycle (light 08:30 to 20:30) and allowed free access to tap water and rat chow.
Reagents Yohimbin HCl was from Nacalai Tesque; prazosin HCl, naltrexone HCl, and atenolol from Wako Pure Chemical Industries; and ICI-118,511 Na salt Stress Loading and Drug Administration Restraint stress loading was performed by the method previously reported. 1) Each rat was immobilized in an adjustable restraint device for 3 h. a-and b-adrenergic antagonists (1.0 mg/kg) were administered intraperitoneally 10 min before stress loading. Footshock stimulus was performed by applying a constant current (0.6 mA) for 2 s every 30 s for 0.5 h using a three-channel footshock generator as reported previously. 10) Mixed stress was administered for 3 h with restraint stress immediately after 0.5 h footshock stress. Norepinephrine (0.4 mg/kg) was intraperitoneally administered to each normal rat. a-and b-adrenergic antagonists (1.0 mg/kg) were intraperitoneally injected 10 min before the administration of norepinephrine.
Measurement of Gastric Emptying Gastric emptying was evaluated based on the stomach weight per rat weight.
Statistics All values are expressed as meanϮS.E.M. The differences between groups were analyzed by one-way analysis of variance (ANOVA) followed by Fisher's protected least-significant difference test (PLSD), with a significance level of pϽ0.05. Figure 1 shows the effect of restraint stress, footshock stress and restraint stress after footshock stress (mixed stress) on gastric emptying. The gastric emptying was significantly inhibited by restraint stress but not by footshock stress. Moreover, footshock stress did not affect the inhibition of gastric emptying by restraint stress. Figure 2 shows the effects of a-and b-adrenergic antagonists on the inhibition of gastric emptying by restraint stress. Prazosin (a 1 -adrenergic antagonist), yohimbine (a 2 -adrenergic antagonist), atenolol (b 1 -adrenergic antagonist), and ICI-118,551 (b 2 -adrenergic antagonist) did not affect restraint stress-induced inhibition of gastric emptying. On the other hand, SR59230A (b 3 -adrenergic antagonist) significantly cancelled restraint stress-induced inhibition of gastric emptying. Figure 3 shows the effects of a-and b-adrenergic antagonists on the inhibition of gastric emptying by norepinephrine treatment. Norepinephrine significantly inhibited gastric emptying. Prazosin and yohimbin did not affect norepinephrine-induced inhibition of gastric emptying. On the other hand, atenolol, ICI-118,551, and SR59230A significantly cancelled norepinephrine-induced inhibition of gastric emptying.
RESULTS
DISCUSSION
We have proposed a possible mechanism for the inhibition of small intestinal motility by restraint and footshock stress and norepinephrine treatment. [3] [4] [5] In the present study, we attempted to ascertain whether or not the mechanism of the inhibition of gastric emptying by restraint and footshock stress and norepinephrine treatment is similar to that of small intestinal motility.
Restraint stress significantly inhibited gastric emptying. a 1 -, a 2 -, b 1 -, and b 2 -adrenoceptor antagonists did not affect this restraint stress-induced inhibition of gastric emptying. On the other hand, the b 3 -adrenoceptor antagonist significantly cancelled this restraint stress-induced inhibition of gastric emptying. These results suggest that b 3 -adrenoceptors are involved in the inhibition of gastric emptying by restraint stress. This involvement of b 3 -adrenoceptors may be supported by the reports that b 3 -adrenoceptor gene expression was detected in the stomach. 11, 12) The involvement of b 3 -adrenoceptors in the inhibition of gastric emptying by restraint stress suggests that the same mechanism occurs in restraint stress-induced inhibition of small intestinal motility and gastric emptying. On the other hand, footshock stress did not affect gastric emptying. This result is identical to that reported by Galligan et al. 13) We previously reported that footshock stimulus canceled the inhibition of small intestinal motility by restraint stress.
4) The inhibition of gastric emptying by restraint stress, however, was not canceled by footshock stress. This result suggests that b-endorphin released by footshock stress does not directly affect b 3 -adrenoceptors in the stomach. Pretreatment with naltrexone significantly inhibited gastric emptying in footshock stress-loaded rats. Wittert et al. reported that m-opioid receptor gene expression was not detected in the stomach of rats.
14) Improta and Broccardo reported that m-opioid agonists inhibit gastric emptying, with intracerebroventicular injection inducing more potent inhibition than subcutaneous administration. 15) Considering those reports and our results, we believe that footshockinduced essential inhibition of gastric emptying by the peripheral nervous system may be canceled by the central nervous system, and consequently the inhibition of gastric emptying by footshock stress may not be observed.
Norepinephrine also significantly inhibited gastric emptying. Pretreatment with a 1 -and a 2 -adrenoceptor antagonists did not affect the inhibition of gastric emptying by norepinephrine treatment. On the other hand, b 1 -, b 2 -, and b 3 -adrenoceptor antagonists significantly cancelled the inhibition of gastric emptying by norepinephrine treatment. These results indicate that the mechanisms of inhibition of gastric emptying due to restraint stress and norepinephrine treatment are different. These results suggest that restraint stress-induced inhibition of gastric emptying does not occur only by stimulation of the sympathetic nervous system, i.e., a more complicated inhibitory pathway may occur in restraint stress than norepinephrine treatment. Moreover, the effect of norepinephrine on gastric emptying differs from that on small intestinal motility, in which b 3 -adrenoceptor antagonists did not cancel the inhibition of norepinephrine-induced small intestinal motility. 5) The results of the present study suggest that 1) b 3 -adrenoceptors play an important role in the inhibition of gastric emptying caused by restraint stress; 2) nonspecific b-adrenoceptors are involved in the inhibition of gastric emptying caused by norepinephrine treatment; 3) the effect of footshock stress on gastric emptying is controlled by an interaction between opioidergic and other central nervous pathways; and 4) the mechanisms of the inhibition of gastric emptying by restraint and footshock stress and norepinephrine treatment differ from these of small intestinal motility.
